{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:44:33Z","timestamp":1794599073346,"version":"4.9.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate differences in outcomes of acute retinal necrosis with confirmed viral polymerase chain reaction between viral types and highlight different treatment options.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The study evaluated 22 eyes in 18 patients of polymerase chain reaction-positive acute retinal necrosis at the University of Pittsburgh Medical Center from 2007 to 2018. Outcome measures included final visual acuity, treatment paradigms, and retinal detachment rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eight eyes were polymerase chain reaction-positive for varicella zoster virus, two eyes for herpes simplex virus Type 1 (HSV-1), and 12 eyes for herpes simplex virus Type 2 (HSV-2). Final Snellen best-corrected visual acuity averaged 20\/51 for varicella zoster virus, 20\/25 for HSV-1, and 20\/814 for HSV-2. Retinal detachment occurred in 2 (25%) of varicella zoster virus eyes and 8 (75%) of HSV-2 eyes. One eye with HSV-1 and three eyes with HSV-2 received cidofovir for treatment of refractory retinitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Acute retinal necrosis secondary to HSV-2 tended to have persistent active retinitis with a higher rate of retinal detachment despite similar treatment protocols, suggesting that in some cases combination intravenous acyclovir and adjuvant intravitreal foscarnet injections are not sufficient. Despite the risk of renal toxicity, intravenous cidofovir may be a consideration in select patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003058","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T20:19:29Z","timestamp":1607631569000},"page":"1547-1552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["ACUTE RETINAL NECROSIS"],"prefix":"10.1097","volume":"41","author":[{"given":"Benjamin W.","family":"Botsford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","first-page":"607","article-title":"Unilateral acute uveitis with periarteritis and detachment","volume":"25","author":"Urayama","year":"1971","journal-title":"Jpn J Clin Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/eye.2011.338","article-title":"Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study","volume":"26","author":"Cochrane","year":"2012","journal-title":"Eye"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/bjo.2007.114884","article-title":"Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK","volume":"91","author":"Muthiah","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R4-20250607","first-page":"663","article-title":"Standard diagnostic criteria for the acute retinal necrosis syndrome","volume":"117","author":"Holland","year":"1994","journal-title":"Executive Committee Am Uveitis Soc Am J Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2017.05.006","article-title":"Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction\u2013positive patients","volume":"179","author":"Butler","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ophtha.2009.09.001","article-title":"Treatment of acute retinal necrosis","volume":"117","author":"Tibbetts","year":"2010","journal-title":"Ophthalmology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ophtha.2006.08.037","article-title":"Acute retinal necrosis features, management, and outcomes","volume":"114","author":"Lau","year":"2007","journal-title":"Ophthalmology"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/09273948.2013.819928","article-title":"Acute retinal necrosis: clinical features, management and outcomes--a 10 year consecutive case series","volume":"22","author":"Roy","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/2474126418798559","article-title":"Acute retinal necrosis multicenter case series: prognostic indicators and treatment outcomes","volume":"2","author":"Dorman","year":"2018","journal-title":"J VitreoRetinal Dis"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0161-6420(82)34638-2","article-title":"The acute retinal necrosis syndrome. Part 2: histopathology and etiology","volume":"89","author":"Culbertson","year":"1982","journal-title":"Ophthalmology"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0002-9394(99)00316-5","article-title":"Viral causes of the acute retinal necrosis syndrome","volume":"129","author":"Ganatra","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2016.11.007","article-title":"Diagnosis and treatment of acute retinal necrosis: a report by the American academy of ophthalmology","volume":"124","author":"Schoenberger","year":"2017","journal-title":"Ophthalmology"},{"key":"R13-20250607","article-title":"Epstein-barr virus acute retinal necrosis in an immunocompetent host","author":"Chan","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2014.266","article-title":"Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation","volume":"132","author":"Schaal","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ophtha.2009.08.003","article-title":"Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome","volume":"117","author":"Wong","year":"2010","journal-title":"Ophthalmology"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ophtha.2008.03.005","article-title":"Acute retinal necrosis in Japan","volume":"115","author":"Usui","year":"2008","journal-title":"Ophthalmology"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08820530802111192","article-title":"Therapy for acute retinal necrosis","volume":"23","author":"Kawaguchi","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(01)00556-5","article-title":"Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients","volume":"108","author":"Van Gelder","year":"2001","journal-title":"Ophthalmology"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9394(99)00391-8","article-title":"High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan","volume":"129","author":"Itoh","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/09273948.2018.1501494","article-title":"Bilateral acute retinal necrosis: clinical features and outcomes in a multicenter study","volume":"27","author":"Miserocchi","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajo.2018.02.001","article-title":"Comparing treatment of acute retinal necrosis with either oral valacyclovir or intravenous acyclovir","volume":"188","author":"Baltinas","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JVI.06620-11","article-title":"In Vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype Associations and highlight differences between antiherpesvirus drugs","volume":"86","author":"Andrei","year":"2012","journal-title":"J Virol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jac\/dkg354","article-title":"Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact","volume":"52","author":"Baldanti","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.10175","article-title":"Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus","volume":"68","author":"Saijo","year":"2002","journal-title":"J Med Virol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2019.08.007","article-title":"Acute retinal necrosis: virological features using quantitative polymerase chain reaction, therapeutic management, and clinical outcomes","volume":"208","author":"Hafidi","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09273948.2016.1207788","article-title":"Treatment of refractory acute retinal necrosis with intravenous foscarnet or cidofovir","volume":"26","author":"Stryjewski","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICB.0000000000000096","article-title":"Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent","volume":"8","author":"Dokey","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0091270002239705","article-title":"Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis","volume":"43","author":"Wolf","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2019.05.023","article-title":"Risk of rhegmatogenous retinal detachment in acute retinal necrosis with and without prophylactic intervention","volume":"206","author":"Risseeuw","year":"2019","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:06:54Z","timestamp":1749319614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003058"}},"subtitle":["Difference in Outcome by Viral Type and Options for Antiviral Therapy"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003058","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}